New Patents Issued to Diffusion Pharmaceuticals
21:00 EDT 15 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Diffusion Pharmaceuticals LLC, a biotechnology company focused on
innovative cancer treatments, today announced that the U.S. Patent and
Trademark Office has granted it patent numbers 7919527 and 8030350,
entitled “Bipolar Tra...
Other Sources for this Article
Diffusion Pharmaceuticals LLC
Media:
David G. Kalergis, MBA/JD
CEO
434-220-0718
dkalergis@diffusionpharma.com
or
GBM
Study Information:
Kim Whitten, Pharm.D,
Vice President, Drug
Development
434-220-0718
kwhitten@diffusionpharma.com
More From BioPortfolio on "New Patents Issued to Diffusion Pharmaceuticals"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
